A quantitative pharmacology model for cannabinoid CB1 receptor mediated by Gi/Gs protein competition

被引:0
|
作者
Yang, Liang [1 ]
Finlay, David B. [2 ]
Green, Hayley M. [2 ]
Zhu, Xiao [3 ]
Glass, Michelle [2 ]
Duffull, Stephen [1 ,4 ]
机构
[1] Univ Otago, Sch Pharm, Otago Pharmacometr Grp, POB 56, Dunedin, New Zealand
[2] Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand
[3] Fudan Univ, Sch Pharm, Dept Clin Pharm & Pharm Adm, Shanghai, Peoples R China
[4] Certara, Princeton, NJ USA
关键词
CB1; receptor; cyclic AMP; G protein; mathematical model; CONCURRENT STIMULATION; AGONIST; ACTIVATION; EXPRESSION; MECHANISM; G(I/O); G(S);
D O I
10.1111/bph.16293
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Purpose: Orthosteric agonism of the CB1 receptor normally associates with Gi signalling resulting in a net inhibition of cAMP production. Empirical evidence shows CB1 causes a net cAMP stimulation through Gs coupling under two conditions: co-stimulation with the D-2 receptor and high-level CB1 expression. Two hypotheses have been proposed to account for these paradoxical effects, (1) Gi is consumed by coupling to D-2 or extra CB1 and excess CB1 binds to Gs and (2), the formation of dimers CB1-CB1 or CB1-D-2 switches Gi/Gs preference. This study explored the mechanisms of Gi/Gs preference based on a mathematical model of the CB1 receptor.Experimental Approach: The model was based on Hypothesis 1 and known mechanisms. The model was calibrated to align with multiple types of data (cAMP, Gi dissociation and internalisation). The key step of Hypothesis 1 was examined by simulation from the model. An experiment was proposed to distinguish Hypothesis 1 and 2.Key Results: The model successfully descripted multiple types of data under Hypothesis 1. Simulations from the model indicated that precoupling of G protein with receptors is necessary for this hypothesis. The model designed experiments to distinguish Hypothesis 1 and 2 by increasing Gi & Gs in parallel with CB1 overexpression. The two hypotheses result in distinct cAMP responses.Conclusion and Implications: A mathematical model of CB1-regulated Gi/Gs pathways was developed. It indicated Hypothesis 1 is feasible and G protein precoupling is a key step causing cAMP signalling switch. The model-designed experiments provided guides for future experimentation.
引用
收藏
页码:1324 / 1340
页数:17
相关论文
共 50 条
  • [31] Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
    Calandra, B
    Portier, M
    Kernéis, A
    Delpech, M
    Carillon, C
    Le Fur, G
    Ferrara, P
    Shire, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 374 (03) : 445 - 455
  • [32] Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat
    Arguello, PA
    Jentsch, JD
    PSYCHOPHARMACOLOGY, 2004, 177 (1-2) : 141 - 150
  • [33] Palmitoylation influences CB1 cannabinoid receptor-G protein interaction
    Mukhopadhyay, S
    Lewis, DL
    Howlett, AC
    FASEB JOURNAL, 2004, 18 (04): : A581 - A582
  • [34] CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
    Gomez, del Pulgar, Teresa
    Velasco, Guillermo
    Guzman, Manuel
    Biochemical Journal, 2000, 347 (pt 2) : 369 - 373
  • [35] Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells
    Xiao, Jing Chen
    Jewell, James P.
    Lin, Linus S.
    Hagmann, William K.
    Fong, Tung M.
    Shen, Chun-Pyn
    BRAIN RESEARCH, 2008, 1238 : 36 - 43
  • [36] Cannabinoid CB1 and CB2 Receptor Signaling and Bias
    Ibsen, Mikkel Soes
    Connor, Mark
    Glass, Michelle
    CANNABIS AND CANNABINOID RESEARCH, 2017, 2 (01) : 48 - 60
  • [37] Central antinociception induced by μ-opioid receptor agonist morphine, but not δ- or κ-, is mediated by cannabinoid CB1 receptor
    Pacheco, Daniela da Fonseca
    Klein, Andre
    Perez, Andrea Castro
    da Fonseca Pacheco, Cinthia Mara
    de Francischi, Janetti Nogueira
    Lopes Reis, Glaucia Maria
    Gama Duarte, Igor Dimitri
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) : 225 - 231
  • [38] Changes in the density of the cannabinoid CB1 receptor in schizophrenia
    Sundram, S
    Bradbury, R
    Scarr, E
    Copolov, DL
    Dean, B
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 85 - 85
  • [39] Receptor dimerization of the μ-opioid and cannabinoid CB1 receptors
    Uezono, Y
    Matsumoto, M
    Kanaide, M
    Hojo, M
    Sumikawa, K
    Taniyama, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 134P - 134P
  • [40] The cannabinoid CB1 receptor is expressed in pancreatic δ-cells
    Tharp, William G.
    Lee, Yong-Ho
    Maple, Rhonda L.
    Pratley, Richard E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (04) : 595 - 600